If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksStreaksai Regulatory News (STK)

  • There is currently no data for STK

Operations Update

24 Jan 2025 10:01

RNS Number : 6289U
StreaksAI PLC
24 January 2025
 

24 January 2025

 

StreaksAI PLC 

("StreaksAI" or "the Company") 

Operations Update

StreaksAI PLC (LSE: STK), is pleased to update shareholders regarding its recent activities, strategic direction, and core focus.

Artificial Intelligence

StreaksAI has been focussed on supporting Artificial Intelligence ("AI") opportunities. One such project is a sentient AI trading agent, called "AROK".

AROK is an automated venture capital agent based on AI that uses sophisticated automated methods to support and innovate on investments in the meme coin space. It has over US$1.27M in meme coins under management.

StreaksAI currently holds 50M AROK.VC tokens. As of 23 January 2025, these tokens have a market value of US$0.01235 SOL per token (US$617,500), as derived from Dex Screener.[1] Due to potential market illiquidity and/or volatility the actual value of such tokens may differ from the market value at any point in time.

AI Researcher and Developer, Leo Mercier, said: "Humans trade with varying degrees of emotion. AROK trades only with data. Arok is building the foundation for autonomous AI agents to reshape a major part of the financial stack and the combination of humans and AI has great potential benefits."

Matthew Lodge, CEO of StreaksAI, said: "The convergence of AI agents and digital assets represents the next wave of value creation. StreaksAI's unique position as both a builder and investor allows us to shape this future from the ground up, turning exponential technologies into exponentially rewarding opportunities."

End

For further information please contact:

 

StreaksAI PLC

 

Matthew Lodge

via First Sentinel (Financial Advisor)

 

Financial Adviser

 

Brian Stockbridge (First Sentinel Corporate Finance Limited)

+44 20 3855 5551 

 

DISCLAIMER

This announcement may contain forward-looking statements. The forward-looking statements include, but are not limited to, statements regarding the Company's, or the Directors' expectations, hopes, beliefs, intentions or strategies regarding the future. In addition, any statement that refers to projections, forecasts or other characterisations of future events or circumstances, including any underlying assumptions, is a forward-looking statement. The words "anticipate", "believe", "continue", "could", "estimate", "expect", "intend", "may", "might", "plan", "possible", "potential", "predict", "project", "seek", "should", "would" and similar expressions, or in each case their negatives, may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking.

Forward-looking statements include all matters that are not historical facts. Forward-looking statements are based on the current expectations and assumptions regarding the Company, the business, the economy and other future conditions. Because forward-looking statements relate to the future, by their nature, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Forward-looking statements are not guarantees of future performance and the Company's actual financial condition, actual results of operations and financial performance, and the development of the industries in which it operates or will operate, may differ materially from those made in or suggested by the forward-looking statements contained in this announcement. In addition, even if the Company's financial condition, results of operations and the development of the industries in which it operates or will operate, are consistent with the forward-looking statements contained in this announcement, those results or developments may not be indicative of financial condition, results of operations or developments in subsequent periods. Important factors that could cause actual results to differ materially from those in the forward-looking statements include regional, national or global, political, economic, social, business, technological, competitive, market and regulatory conditions.

Any forward-looking statement contained in this announcement applies only as of the date of this announcement and is expressly qualified in its entirety by these cautionary statements. Factors or events that could cause the Company's actual results to differ may emerge from time to time, and it is not possible for the Company to predict all of them. The Company expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained in this announcement to reflect any change in its expectations or any change in events, conditions or circumstances on which any forward-looking statement contained in this announcement is based, unless required to do so by applicable law, the London Stock Exchange Rules, the Disclosure Guidance and Transparency Rules of the FCA or the UK Market Abuse Regulation.

 

[1] https://dexscreener.com/solana/Cwe5k2iEy8dt7vCGY93GBrqQS4FWyac6pQjvjLcPD6qp

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDBIMLTMTATMPA
12
Date   Source Headline
13th May 20253:26 pmRNSChange of Company Name and Strategic Update
29th Jan 20257:00 amRNSExercise of Warrants, PDMR and Grant of Warrants
24th Jan 202510:01 amRNSOperations Update
16th Jan 20259:23 amRNSLeadership Changes and Board Appointments
15th Jan 202512:20 pmRNSNotification of Investment
26th Nov 20249:43 amRNSTR-1 Notification
22nd Nov 20247:00 amRNSIssue of Warrants and PDMR
21st Nov 20247:00 amRNSIssue of Equity and PDMR
18th Nov 20247:00 amRNSInterim results
2nd Aug 202411:16 amRNSDirector Resignation
25th Jul 20245:57 pmRNSResults of Annual General Meeting
4th Jul 20244:28 pmRNSNotice of Annual General Meeting
28th Jun 20247:00 amRNSAnnual results
11th Mar 202410:31 amRNSDirector's Dealings
4th Mar 20245:09 pmRNSDirector Resignation
2nd Feb 202410:02 amRNSDirector Resignation
19th Dec 20231:10 pmRNSDirector's Dealings and TR-1 Notification
30th Nov 20237:00 amRNSInterim Results
2nd Nov 20237:00 amRNSLaunch of Streaks Companion
21st Sep 20237:00 amRNSLaunch of Streaks Idols Social Product
29th Aug 20237:00 amRNSChange of Board Composition
16th Aug 202312:45 pmRNSResults of Annual General Meeting
3rd Aug 20237:00 amRNSPartnership with WeShop
17th Jul 20237:00 amRNSNotice of AGM
10th Jul 20237:00 amRNSChange of Name
30th Jun 20237:03 amRNSAnnual Results
30th Jun 20237:00 amRNSStreaks Social AI Product Launch / Warrants Issue
24th Mar 20237:00 amRNSAdvertising Partnership with William Hill US
20th Feb 20237:00 amRNSBoard Appointments
2nd Feb 20237:00 amRNSFanDuel Partnership
18th Jan 20237:00 amRNSYear-over-Year Performance
5th Jan 20237:00 amRNSAdmission to the Official List
8th Aug 200810:08 amRNSStatement re Forecast of Year
10th Jun 200812:16 pmRNSStatement re Dividends Receip
6th Jun 200811:06 amRNSStatement re Partial Correcti
30th May 200810:17 amRNSStatement re Concerning Disso
23rd May 200812:47 pmRNSStatement re Announcement of
23rd May 200810:50 amRNSRe Partial Changes in Article
23rd May 200810:32 amRNSStatement re Concerning Parti
23rd May 200810:29 amRNSStatement re Correction of Fi
23rd May 200810:15 amRNSStatement re Conceming Correc
25th Apr 200812:46 pmRNSAcquisition of Shares
25th Apr 200812:42 pmRNSValuation.@Loss
27th Mar 20089:28 amRNSStatement re Transfer
31st Jan 200812:01 pmRNSStatement re Special Loss
28th Nov 200710:31 amRNSStatement re Earnings
29th Jun 200710:08 amRNSStatement re Securitization
22nd Jun 200711:43 amRNSStatement re (Dividend)
21st Jun 20071:14 pmRNSPartial Correction
19th Jun 20073:33 pmRNSStatement re Affiliated Co
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.